Combined targeting of MEK and the glucocorticoid receptor for the treatment of RAS-mutant multiple myeloma. (2020)

First Author: Sriskandarajah P

Attributed to: UoEdinburgh Confidence in Concept 2013 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12885-020-06735-2

PubMed Identifier: 32228485

Publication URI: http://europepmc.org/abstract/MED/32228485

Type: Journal Article/Review

Volume: 20

Parent Publication: BMC cancer

Issue: 1

ISSN: 1471-2407